Drugs / E1018
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06854042 | Feb → Dec 2025 overdue | malaria | Eisai Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E1018 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06854042 ↗ |
| Route | Oral | “single ascending oral doses of E1018” NCT06854042 ↗ |